Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 May;89(5):1496–1500. doi: 10.1172/JCI115740

Intracellular signaling in the regulation of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase A2.

T Satoh 1, H T Cohen 1, A I Katz 1
PMCID: PMC443020  PMID: 1349027

Abstract

We have reported that dopamine (DA) inhibits Na-K-ATPase activity in the cortical collecting duct (CCD) by stimulating the DA1 receptor, and the present study was designed to evaluate the mechanism of this effect. Short-term exposure (15-30 min) of microdissected rat CCD to DA, a DA1 agonist (fenoldopam), vasopressin (AVP), forskolin, or dibutyryl cAMP (dBcAMP), which increase cAMP content by different mechanisms, strongly (approximately 60%) inhibited Na-K-ATPase activity. 2',5'-dideoxyadenosine, an inhibitor of adenylate cyclase, completely blocked Na-K-ATPase inhibition by DA or fenoldopam, and IP20, an inhibitor peptide of cAMP-dependent protein kinase A (PKA), abolished the Na:K pump effect of all the cAMP agonists listed above. To verify whether the mechanism of pump inhibition by agents that increase cell cAMP involves phospholipase A2 (PLA2), we used mepacrine, a PLA2 inhibitor, which also abolished Na-K-ATPase inhibition by DA or fenoldopam, as well as by AVP, forskolin, or dBcAMP. Arachidonic acid (10(-7) - 10(-4) M) inhibited Na-K-ATPase activity in dose-dependent fashion. Corticosterone, which induces lipomodulin, a PLA2 inhibitor protein inactivated by PKA, equally abolished the pump effects of DA, fenoldopam, forskolin, and dBcAMP, suggesting that lipomodulin might act between PKA and PLA2 in cAMP-dependent pump regulation. We conclude that dopamine inhibits Na-K-ATPase activity in the CCD through a DA1 receptor-mediated cAMP-PKA pathway that involves the stimulation of PLA2 and arachidonic acid release, possibly mediated by inactivation of lipomodulin. This pathway is shared by other agonists that increase cell cAMP and thus stimulate PKA activity.

Full text

PDF
1499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aperia A., Bertorello A., Seri I. Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol. 1987 Jan;252(1 Pt 2):F39–F45. doi: 10.1152/ajprenal.1987.252.1.F39. [DOI] [PubMed] [Google Scholar]
  2. Aperia A., Fryckstedt J., Svensson L., Hemmings H. C., Jr, Nairn A. C., Greengard P. Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2798–2801. doi: 10.1073/pnas.88.7.2798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bertorello A., Aperia A. Inhibition of proximal tubule Na(+)-K(+)-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol. 1990 Dec;259(6 Pt 2):F924–F928. doi: 10.1152/ajprenal.1990.259.6.F924. [DOI] [PubMed] [Google Scholar]
  4. Bertorello A., Aperia A. Na+-K+-ATPase is an effector protein for protein kinase C in renal proximal tubule cells. Am J Physiol. 1989 Feb;256(2 Pt 2):F370–F373. doi: 10.1152/ajprenal.1989.256.2.F370. [DOI] [PubMed] [Google Scholar]
  5. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  6. Cheng H. C., Kemp B. E., Pearson R. B., Smith A. J., Misconi L., Van Patten S. M., Walsh D. A. A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem. 1986 Jan 25;261(3):989–992. [PubMed] [Google Scholar]
  7. Doucet A., Katz A. I., Morel F. Determination of Na-K-ATPase activity in single segments of the mammalian nephron. Am J Physiol. 1979 Aug;237(2):F105–F113. doi: 10.1152/ajprenal.1979.237.2.F105. [DOI] [PubMed] [Google Scholar]
  8. Felder C. C., Blecher M., Jose P. A. Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes. J Biol Chem. 1989 May 25;264(15):8739–8745. [PubMed] [Google Scholar]
  9. Felder C. C., Jose P. A., Axelrod J. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther. 1989 Jan;248(1):171–175. [PubMed] [Google Scholar]
  10. Felder R. A., Blecher M., Calcagno P. L., Jose P. A. Dopamine receptors in the proximal tubule of the rabbit. Am J Physiol. 1984 Sep;247(3 Pt 2):F499–F505. doi: 10.1152/ajprenal.1984.247.3.F499. [DOI] [PubMed] [Google Scholar]
  11. Felder R. A., Felder C. C., Eisner G. M., Jose P. A. The dopamine receptor in adult and maturing kidney. Am J Physiol. 1989 Sep;257(3 Pt 2):F315–F327. doi: 10.1152/ajprenal.1989.257.3.F315. [DOI] [PubMed] [Google Scholar]
  12. Flower R. J., Blackwell G. J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979 Mar 29;278(5703):456–459. doi: 10.1038/278456a0. [DOI] [PubMed] [Google Scholar]
  13. Frederickson E. D., Bradley T., Goldberg L. I. Blockade of renal effects of dopamine in the dog by the DA1 antagonist SCH 23390. Am J Physiol. 1985 Aug;249(2 Pt 2):F236–F240. doi: 10.1152/ajprenal.1985.249.2.F236. [DOI] [PubMed] [Google Scholar]
  14. Hirata F. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem. 1981 Aug 10;256(15):7730–7733. [PubMed] [Google Scholar]
  15. Huo T., Healy D. P. Autoradiographic localization of dopamine DA1 receptors in rat kidney with [3H]Sch 23390. Am J Physiol. 1989 Sep;257(3 Pt 2):F414–F423. doi: 10.1152/ajprenal.1989.257.3.F414. [DOI] [PubMed] [Google Scholar]
  16. Hébert R. L., Jacobson H. R., Breyer M. D. Prostaglandin E2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium. J Clin Invest. 1991 Jun;87(6):1992–1998. doi: 10.1172/JCI115227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kinoshita S., Ohlstein E. H., Felder R. A. Dopamine-1 receptors in rat proximal convoluted tubule: regulation by intrarenal dopamine. Am J Physiol. 1990 Apr;258(4 Pt 2):F1068–F1074. doi: 10.1152/ajprenal.1990.258.4.F1068. [DOI] [PubMed] [Google Scholar]
  18. Lee S. M., Chekal M. A., Katz A. I. Corticosterone binding sites along the rat nephron. Am J Physiol. 1983 May;244(5):F504–F509. doi: 10.1152/ajprenal.1983.244.5.F504. [DOI] [PubMed] [Google Scholar]
  19. Lingham R. B., Sen A. K. Regulation of rat brain (Na+ +K+)-ATPase activity by cyclic AMP. Biochim Biophys Acta. 1982 Jun 14;688(2):475–485. doi: 10.1016/0005-2736(82)90359-5. [DOI] [PubMed] [Google Scholar]
  20. Londos C., Wolff J. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5482–5486. doi: 10.1073/pnas.74.12.5482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Majerus P. W., Connolly T. M., Deckmyn H., Ross T. S., Bross T. E., Ishii H., Bansal V. S., Wilson D. B. The metabolism of phosphoinositide-derived messenger molecules. Science. 1986 Dec 19;234(4783):1519–1526. doi: 10.1126/science.3024320. [DOI] [PubMed] [Google Scholar]
  22. Meister B., Fryckstedt J., Schalling M., Cortés R., Hökfelt T., Aperia A., Hemmings H. C., Jr, Nairn A. C., Ehrlich M., Greengard P. Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8068–8072. doi: 10.1073/pnas.86.20.8068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sadler S. E., Maller J. L. Inhibition of Xenopus oocyte adenylate cyclase by progesterone and 2',5'-dideoxyadenosine is associated with slowing of guanine nucleotide exchange. J Biol Chem. 1983 Jul 10;258(13):7935–7941. [PubMed] [Google Scholar]
  24. Schwartzman M., Ferreri N. R., Carroll M. A., Songu-Mize E., McGiff J. C. Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase. Nature. 1985 Apr 18;314(6012):620–622. doi: 10.1038/314620a0. [DOI] [PubMed] [Google Scholar]
  25. Seamon K. B., Padgett W., Daly J. W. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3363–3367. doi: 10.1073/pnas.78.6.3363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Siragy H. M., Felder R. A., Howell N. L., Chevalier R. L., Peach M. J., Carey R. M. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol. 1989 Sep;257(3 Pt 2):F469–F477. doi: 10.1152/ajprenal.1989.257.3.F469. [DOI] [PubMed] [Google Scholar]
  27. Takemoto F., Satoh T., Cohen H. T., Katz A. I. Localization of dopamine-1 receptors along the microdissected rat nephron. Pflugers Arch. 1991 Oct;419(3-4):243–248. doi: 10.1007/BF00371102. [DOI] [PubMed] [Google Scholar]
  28. Torikai S., Kurokawa K. Effect of PGE2 on vasopressin-dependent cell cAMP in isolated single nephron segments. Am J Physiol. 1983 Jul;245(1):F58–F66. doi: 10.1152/ajprenal.1983.245.1.F58. [DOI] [PubMed] [Google Scholar]
  29. Tria E., Luly P., Tomasi V., Trevisani A., Barnabei O. Modulation by cyclic AMP in vitro of liver plasma membrane (Na+--K+)-ATPase and protein kinases. Biochim Biophys Acta. 1974 Apr 22;343(2):297–306. doi: 10.1016/0304-4165(74)90094-4. [DOI] [PubMed] [Google Scholar]
  30. Tung P., Pai G., Johnson D. G., Punzalan R., Levin S. R. Relationships between adenylate cyclase and Na+, K(+)-ATPase in rat pancreatic islets. J Biol Chem. 1990 Mar 5;265(7):3936–3939. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES